Report Detail
Global Biologic Medication in COVID-19 Market Size, Status and Forecast 2020-2026
- RnM3951744 |
- 17 April, 2020 |
- Global |
- 95 Pages |
- QYResearch |
- Pharma & Healthcare
According to China's clinical trials of COVID-19 treatment, the number of chemical drugs accounted for the highest proportion, followed by biological drugs, cell therapy, vaccines, and traditional Chinese medicine. Among the biological drugs, IL-6 related monoclonal antibodies (anti-inflammatory) account for the largest proportion, including tocilizumab and Sarilumab. This report focuses on the investigation and analysis of biologic medication and predicts the future market development of biopharmaceuticals under the influence of COVID-19. Biological drugs are mainly divided into two categories: neutralizing antibodies and anti-inflammatory drugs. The main subdivisions include: IL-6, C5a, CD147, PD-1 and Interferon (beta-1a), etc.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biologic Medication in COVID-19 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Biologic Medication in COVID-19 industry.
Based on our recent survey, we have several different scenarios about the Biologic Medication in COVID-19 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biologic Medication in COVID-19 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biologic Medication in COVID-19 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biologic Medication in COVID-19 market in terms of revenue.
Players, stakeholders, and other participants in the global Biologic Medication in COVID-19 market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Biologic Medication in COVID-19 market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Biologic Medication in COVID-19 market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biologic Medication in COVID-19 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biologic Medication in COVID-19 market.
The following players are covered in this report:
Roche
Sanofi
Novartis
Merck
Bayer
Shutaishen
Biogen
Regeneron Pharmaceuticals
Vir Biotech
Junshi Biosciences
Anke Biotechnology
OncoImmune
Biologic Medication in COVID-19 Breakdown Data by Type
Neutralizing Antibodies
Anti-inflammatory Drugs
Biologic Medication in COVID-19 Breakdown Data by Application
COVID-19
Influenza
Malaria
Others
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Biologic Medication in COVID-19 Revenue
- 1.4 Market Analysis by Type
- 1.4.1 Global Biologic Medication in COVID-19 Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Neutralizing Antibodies
- 1.4.3 Anti-inflammatory Drugs
- 1.5 Market by Application
- 1.5.1 Global Biologic Medication in COVID-19 Market Share by Application: 2020 VS 2026
- 1.5.2 COVID-19
- 1.5.3 Influenza
- 1.5.4 Malaria
- 1.5.5 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Biologic Medication in COVID-19 Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Biologic Medication in COVID-19 Industry
- 1.6.1.1 Biologic Medication in COVID-19 Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Biologic Medication in COVID-19 Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Biologic Medication in COVID-19 Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Biologic Medication in COVID-19 Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends by Regions
- 2.1 Biologic Medication in COVID-19 Market Perspective (2015-2026)
- 2.2 Biologic Medication in COVID-19 Growth Trends by Regions
- 2.2.1 Biologic Medication in COVID-19 Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Biologic Medication in COVID-19 Historic Market Share by Regions (2015-2020)
- 2.2.3 Biologic Medication in COVID-19 Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Biologic Medication in COVID-19 Market Growth Strategy
- 2.3.6 Primary Interviews with Key Biologic Medication in COVID-19 Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Biologic Medication in COVID-19 Players by Market Size
- 3.1.1 Global Top Biologic Medication in COVID-19 Players by Revenue (2015-2020)
- 3.1.2 Global Biologic Medication in COVID-19 Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Biologic Medication in COVID-19 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Biologic Medication in COVID-19 Market Concentration Ratio
- 3.2.1 Global Biologic Medication in COVID-19 Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Biologic Medication in COVID-19 Revenue in 2019
- 3.3 Biologic Medication in COVID-19 Key Players Head office and Area Served
- 3.4 Key Players Biologic Medication in COVID-19 Product Solution and Service
- 3.5 Date of Enter into Biologic Medication in COVID-19 Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Biologic Medication in COVID-19 Historic Market Size by Type (2015-2020)
- 4.2 Global Biologic Medication in COVID-19 Forecasted Market Size by Type (2021-2026)
5 Biologic Medication in COVID-19 Breakdown Data by Application (2015-2026)
- 5.1 Global Biologic Medication in COVID-19 Market Size by Application (2015-2020)
- 5.2 Global Biologic Medication in COVID-19 Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Biologic Medication in COVID-19 Market Size (2015-2020)
- 6.2 Biologic Medication in COVID-19 Key Players in North America (2019-2020)
- 6.3 North America Biologic Medication in COVID-19 Market Size by Type (2015-2020)
- 6.4 North America Biologic Medication in COVID-19 Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Biologic Medication in COVID-19 Market Size (2015-2020)
- 7.2 Biologic Medication in COVID-19 Key Players in Europe (2019-2020)
- 7.3 Europe Biologic Medication in COVID-19 Market Size by Type (2015-2020)
- 7.4 Europe Biologic Medication in COVID-19 Market Size by Application (2015-2020)
8 China
- 8.1 China Biologic Medication in COVID-19 Market Size (2015-2020)
- 8.2 Biologic Medication in COVID-19 Key Players in China (2019-2020)
- 8.3 China Biologic Medication in COVID-19 Market Size by Type (2015-2020)
- 8.4 China Biologic Medication in COVID-19 Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Biologic Medication in COVID-19 Market Size (2015-2020)
- 9.2 Biologic Medication in COVID-19 Key Players in Japan (2019-2020)
- 9.3 Japan Biologic Medication in COVID-19 Market Size by Type (2015-2020)
- 9.4 Japan Biologic Medication in COVID-19 Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Biologic Medication in COVID-19 Market Size (2015-2020)
- 10.2 Biologic Medication in COVID-19 Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Biologic Medication in COVID-19 Market Size by Type (2015-2020)
- 10.4 Southeast Asia Biologic Medication in COVID-19 Market Size by Application (2015-2020)
11 India
- 11.1 India Biologic Medication in COVID-19 Market Size (2015-2020)
- 11.2 Biologic Medication in COVID-19 Key Players in India (2019-2020)
- 11.3 India Biologic Medication in COVID-19 Market Size by Type (2015-2020)
- 11.4 India Biologic Medication in COVID-19 Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Biologic Medication in COVID-19 Market Size (2015-2020)
- 12.2 Biologic Medication in COVID-19 Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Biologic Medication in COVID-19 Market Size by Type (2015-2020)
- 12.4 Central & South America Biologic Medication in COVID-19 Market Size by Application (2015-2020)
13Key Players Profiles
- 13.1 Roche
- 13.1.1 Roche Company Details
- 13.1.2 Roche Business Overview and Its Total Revenue
- 13.1.3 Roche Biologic Medication in COVID-19 Introduction
- 13.1.4 Roche Revenue in Biologic Medication in COVID-19 Business (2015-2020))
- 13.1.5 Roche Recent Development
- 13.2 Sanofi
- 13.2.1 Sanofi Company Details
- 13.2.2 Sanofi Business Overview and Its Total Revenue
- 13.2.3 Sanofi Biologic Medication in COVID-19 Introduction
- 13.2.4 Sanofi Revenue in Biologic Medication in COVID-19 Business (2015-2020)
- 13.2.5 Sanofi Recent Development
- 13.3 Novartis
- 13.3.1 Novartis Company Details
- 13.3.2 Novartis Business Overview and Its Total Revenue
- 13.3.3 Novartis Biologic Medication in COVID-19 Introduction
- 13.3.4 Novartis Revenue in Biologic Medication in COVID-19 Business (2015-2020)
- 13.3.5 Novartis Recent Development
- 13.4 Merck
- 13.4.1 Merck Company Details
- 13.4.2 Merck Business Overview and Its Total Revenue
- 13.4.3 Merck Biologic Medication in COVID-19 Introduction
- 13.4.4 Merck Revenue in Biologic Medication in COVID-19 Business (2015-2020)
- 13.4.5 Merck Recent Development
- 13.5 Bayer
- 13.5.1 Bayer Company Details
- 13.5.2 Bayer Business Overview and Its Total Revenue
- 13.5.3 Bayer Biologic Medication in COVID-19 Introduction
- 13.5.4 Bayer Revenue in Biologic Medication in COVID-19 Business (2015-2020)
- 13.5.5 Bayer Recent Development
- 13.6 Shutaishen
- 13.6.1 Shutaishen Company Details
- 13.6.2 Shutaishen Business Overview and Its Total Revenue
- 13.6.3 Shutaishen Biologic Medication in COVID-19 Introduction
- 13.6.4 Shutaishen Revenue in Biologic Medication in COVID-19 Business (2015-2020)
- 13.6.5 Shutaishen Recent Development
- 13.7 Biogen
- 13.7.1 Biogen Company Details
- 13.7.2 Biogen Business Overview and Its Total Revenue
- 13.7.3 Biogen Biologic Medication in COVID-19 Introduction
- 13.7.4 Biogen Revenue in Biologic Medication in COVID-19 Business (2015-2020)
- 13.7.5 Biogen Recent Development
- 13.8 Regeneron Pharmaceuticals
- 13.8.1 Regeneron Pharmaceuticals Company Details
- 13.8.2 Regeneron Pharmaceuticals Business Overview and Its Total Revenue
- 13.8.3 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Introduction
- 13.8.4 Regeneron Pharmaceuticals Revenue in Biologic Medication in COVID-19 Business (2015-2020)
- 13.8.5 Regeneron Pharmaceuticals Recent Development
- 13.9 Vir Biotech
- 13.9.1 Vir Biotech Company Details
- 13.9.2 Vir Biotech Business Overview and Its Total Revenue
- 13.9.3 Vir Biotech Biologic Medication in COVID-19 Introduction
- 13.9.4 Vir Biotech Revenue in Biologic Medication in COVID-19 Business (2015-2020)
- 13.9.5 Vir Biotech Recent Development
- 13.10 Junshi Biosciences
- 13.10.1 Junshi Biosciences Company Details
- 13.10.2 Junshi Biosciences Business Overview and Its Total Revenue
- 13.10.3 Junshi Biosciences Biologic Medication in COVID-19 Introduction
- 13.10.4 Junshi Biosciences Revenue in Biologic Medication in COVID-19 Business (2015-2020)
- 13.10.5 Junshi Biosciences Recent Development
- 13.11 Anke Biotechnology
- 10.11.1 Anke Biotechnology Company Details
- 10.11.2 Anke Biotechnology Business Overview and Its Total Revenue
- 10.11.3 Anke Biotechnology Biologic Medication in COVID-19 Introduction
- 10.11.4 Anke Biotechnology Revenue in Biologic Medication in COVID-19 Business (2015-2020)
- 10.11.5 Anke Biotechnology Recent Development
- 13.12 OncoImmune
- 10.12.1 OncoImmune Company Details
- 10.12.2 OncoImmune Business Overview and Its Total Revenue
- 10.12.3 OncoImmune Biologic Medication in COVID-19 Introduction
- 10.12.4 OncoImmune Revenue in Biologic Medication in COVID-19 Business (2015-2020)
- 10.12.5 OncoImmune Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Biologic Medication in COVID-19. Industry analysis & Market Report on Biologic Medication in COVID-19 is a syndicated market report, published as Global Biologic Medication in COVID-19 Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Biologic Medication in COVID-19 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
